Biomedical applications of maghemite ferrofluid

Biochimie

Volumn 80, Issue 5-6, 1998, Pages 379-390

  Halbreich, A ^a   Roger, J ^a   Pons, J N ^a   Geldwerth, D ^b   Da Silva, M F ^c   Roudier, M ^d   Bacri, J C ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b INST DE BIOLOGIE PHYSICO CHIMIQUE   (France)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d Hôpital Charles Richet   (France)

Author keywords

Alzheimer's disease; Annexin ferrofluid; Anuexin V; Blood sedimentation rate; Blood storage; Ferrofluid; Magnetic cell sorting; Magnetocytolysis; Malaria

Indexed keywords

ANNEXIN; FERRIC OXIDE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; SUCCIMER;

ALZHEIMER DISEASE; ARTICLE; BIOMEDICINE; BLOOD STORAGE; CELL MEMBRANE; CELL SELECTION; EFFECTOR CELL; ERYTHROCYTE SEDIMENTATION RATE; MAGNETIC FIELD; MALARIA; NONHUMAN; PLASMODIUM; SICKLE CELL ANEMIA; STATISTICAL ANALYSIS;

PLASMODIUM PARASITES;

EID: 0032075852     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)80006-1     Document Type: Article

References (81)

1. 1 Rosensweig RE (1985) Ferrohydrodynamics. Cambridge University Press, Cambridge
2. 2 Shliomis MI (1974) Sov Phys-USP (English translation) 17, 153
3. 3 Kaiser R, Rosensweig RE (1969) Study of ferromagnetic fluid. NASA CR, 1407
4. 4 Massart R (1982) Magnetic fluids and process for obtaining them. US Patent 4 329 241
5. 5 Hasegawa M, Hokkoku S (1978) Magnetic iron oxide-dextran complex and process for its production. US Patent 4 101 435
6. 6 Dutton AH, Tokuyasu KT, Singer J (1979) Iron-dextran antibody conjugates: General method for for simultaneous staining of two components in high resolution immunoelectron microscopy. Proc Natl Acad Sci USA 76, 3392-3396
7. 7 Griffin T, Mosbach K, Mosbach R (1981) Affinity absorbents for Magnetic biospecific immunoglobulin and enzyme isolation. Appl Biochem Biotechnol 6, 283-292
8. 8 Molday RS, Mackenzie D (1982) Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 52, 353-367
9. 9 Scröder U (1983) Magnetic carbohydrate particles as carriers for affinity separation purposes, eg cell separation. PCT Int Appl WO 83 03 426
10. 10 Widder KJ, Senyei AE (1980) Method of magnetic separation of cells and the like, and microspheres for use therein. EU Patent 0 016 552 A1
11. 11 Kandzia J, Haas W, Leyhausen G, Müller-Ruchholz W (1984) Cell separation: Comparison between magnetic immune microspheres (MIMS) and facs. International Meeting on Cell Electrophoresis, Rostock, GDR
12. 12 Renshaw PF, Owen CS, McLaughlin AC, Frey JR (1986) Ferromagnetic contrast agents: A new approach. Magn Res Med 3, 217-225
13. 13 Whitehead RA, Chagnon MS, Groman EV, Josephson L (1987) Magnetic particles for use in separations. US Patent 4 695 392
14. 14 Okada M, Ashihara Y, Yano A, Oishi M, Yoshioka K, Nakamura T (1990) Immunoasay using magnetic particles. EU Patent 0 420 186 A2
15. 15 Wang CH, Shah DO (1991) Magnetically responsive fluorescent polymer particles and application thereof. Internat Patent WO 91/09141
16. 16 Groman EV, Josephson L (1993) Low molecular weight carbohydrates as additives to stabilize metal oxide compositions. US Patent 5 248 492
17. 17 Halbreich A, Sabolovic' D, Sestier C, Geldwerth D, Pons JN, Roger J (1995) Nanoparticules magnétiques couplées à de l'annexine et leur utilisation. Demande de brevet FR 9507865 (PCT/FR96/00964, no de publication 2 736 197) INPI, Paris
18. 18 Halbreich A, Roger J, Pons JN, Da Silva MF, Hasmonay E, Roudier M, Boynard M, Sestier C, Amri A, Geldwerth D, Fertil B, Bacri JC, Sabolovic' D (1997) Magnetic maghemite nanoparticles: their preparation and application in cell sorting and characterization of cellular membranes in vitro. In: Scientific and Clinical Applications of Magnetic Carriers (Häfeli U et al, eds) Plenum Press, New York, 399-417
19. 19 Raynal P, Pollard HB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochim Biophys Acta 1197, 63-93
20. 20 Reuteligsperger C (1991) Use of an anticoagulant as a diagnostic agent. Inernational Patent WO 91/09628
21. 21 Raynal P, Hullin F, Ragab-Thomas JM, Fuvel J, Chap H (1993) Annexin 5 as a potential regulator of annexinn1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells. Biochem J 292, 759-765
22. 22 Koster JJ, Boustead CM, Middleton CA, Walker JH (1993) The subcellular localization of annexin V in cultured chick-embryo fibroblasts. Biochem J 291, 595-600
23. 23 Devaux PF (1992) Protein involvement in transmembrane lipid asymmetry. Ann Rev Biophys Biomol Structure 21, 417-439
24. 24 Le DT, Rapaport SI, Rao LVM (1995) Studies on the mechanism for enhanced cell surface factor via tissue factor activation of factor X on fibroblasts after their exposure to N-ethylmaleimide. Thromb Haemost 72, 848-855
25. 25 Schroit AJ, Madsen JW, Tanaka Y (1985) In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membrane. J Biol Chem 260, 5131-5138
26. 26 Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420
27. 27 Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G (1996) Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 157, 512-521
28. 28 McEvoy L, Williamson P, Schlegel RA (1986) Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci USA 83, 3311-3315
29. 29 Sambrano GR, Steinberg D (1995) Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92, 2179-2184
30. 30 Lubin B, Chiu D, Bastacky J, Roelfsen B, Van Deenen LLM (1981) Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest 67, 1643-1649
31. 31 Tait JF, Gibson D (1994). Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Med 123, 741-748
32. 32 Moumaris M, Sestier C, Miltgen F, Halbreich A, Sabolovic' D (1995) Effect of fatty acids treatment in cerebral malaria susceptible and non-susceptible strains of mice. J Parasitol 81, 997-999
33. 33 Sabolovic D, Moumaris M, Miltgen F, Sestier C, Halbreich A (1995) Characterization of a sub-population of mouse RBC as a preferential target for malarial invasion. Int Congress of Electrophoresis, Paris, 30.8-2.9.1995
34. 34 Sestier C, Sabolovic' D, Geldwerth D, Moumaris M, Roger J, Pons JN, Albreich A (1995) Use of annexin V-ferrofluid to enumerate erythrocytes damaged in various pathologies or during storage in vitro. CR Acad Sci Paris 318, 1141-1146
35. 35 Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH (1996) Detection of altered membrane phospho-lipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 87, 1179-187
36. 36 Wood BL, Gibson DF, Tait JF (1996). Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations. Blood 88, 1873-1880
37. 37 Taverne J, van Schie R, Playfair J, Reutelinsperger CPM (1995) Malaria: Phosphatidylserine expression is not increased on the surface of parasitized erythrocytes. Parasitol Today 11, 298-299
38. 38 Halbreich A, Sabolovic' D, Sestier, Amri A, Pons JN, Roger J, Geldwerth D (1996) Annexin V binding to mouse erythrocytes following infection with Plasmodium parasites. Parasitol Today 12, 292-293
39. 39 Fadok VA, Bratton D (1996) FASEB Summer conference on Molecular Biophysics of Cellular Membranes. Saxtons River, Vermont USA, 20-25 July, 1996
40. 40 Geldwerth D, Devaux PF, Sabolovic' D, Helley D, Roger J, Pons JN, Freyssinet JM, Kuypers FA, Lubin BH, Sorice M, Halbreich A (1996) Exposure of phosphatidylserine at the surface of human erythrocytes during storage in vitro. FASEB Summer Research Conference on Molecular Biophysics of Cellular Membranes. Saxtons River, Vermont, USA, 20-25 July, 1996
41. 41 American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edn, APA, Washington DC
42. 42 Mc Kahnn G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease. In: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
43. 43 Panisset M, Roudier M, Saxton J, Boller F (1994) Severe impairment battery. A neuro-psychological test for severely demented patients. Arch Neurol 51, 41-45
44. 44 Folstein MF, Folstein SE, Mcugh PR (1975) Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198
45. 45 Lovestone S, Reynolds CH (1997) The phosphorylation of tau: a critical stage in neurodevelopmental and neurodegenerative processes. Neuroscience 78, 309-324
46. 46 Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20, 154-159
47. 47 Sulkava R, Kainulainen K, Verkkoniemi A, Niinisto L, Sobel E, Davanipur Z, Polkikovski T, Haltia M, Kontula K (1996) APOE alleles in Aleheimer's disease and vascular dementia in a population aged 85+. Neurobiol Aging 17, 373-376
48. 48 Halisalmi S, Linnaranta K, Lehtovirta M, Mannersmaa A, Heinonen O, Ryynanen M, Pielkkinen P, Soininen H (1996) Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci Lett 205, 61-64
49. 49 Kehoe P, Williams J, Holmans P, Liddel M, Lovestone S, Homes C, Powell J, Neal J, Wilcock G, Owen MJ (1996) Association between a PS-I intronic polymorphism and late onset Alzheimer's disease. Neuroreport 7, 2155-2158
50. 50 Kehoe P, Williams J, Lovestone S, Wilcock MG (1996) UK Alzheimer's Disease Collaborative Group. Confirmation of an association between a presenilin-1 intronic polymorphism and late onset Alzheimer's disease. Lancet 347, 1185
51. 51 Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G, Lesch KP, Powell J, Lovestone S, Collier D (1997) Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 8, 683-686
52. 52 Relkin NR, Tanzi R, Breitner J, Farrer L, Gandy S, Haines J, Hyman B, Mullan M, Poirier J, Strittmatter W, Folstein M, Farlow M, Mayeux R, Petersen R, Roses A, Schenk D, Small G, Vangool W, Cookdeegan R, Fleck L, Kapp M, Karlinsky H, Pericakvance M, Post S, Wolpert C, Berg L, Blass J, Fletcher J, Hegele R, Khachaturian Z, Selkoe D, Thal L, Whitehouse P, Kwon YG (1996) Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347, 1091-1095
53. 53 Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 38, 6-14
54. 54 Farrer LA, Brin MF, Elsas L, Goate A, Kennedy J, Mayeux R, Myers RH, Reilly P, Risch NJ (1995) Statement on use of apolipoprotein E testing in Alzheimer disease J Am Med Assoc 274, 1627
55. 55 Maelicke A, Albuquerque EX (1996) New approach to drug therapy in Alzheimer's dementia. Drug Discovery Today 1, 53-59
56. 56 Bosman GJ, Visser FE, De Man AJ, Bartholomew IG, De Grip WJ (1993) Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia. Neurobiol Aging 14, 223-228
57. 57 Bosman GJ, Bartholomeus IG, De Man AJ, Van Kalmthhout PJ, De Grip WJ (1991) Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. Neurobiol Aging 12, 13-18
58. 58 Soldati L, Alberoni M, Bianchi G, Canal N, Franchesi M (1996) Erythrocytic calpain-calpastatin system in Alzheimer's disease. Aging Clin Exp Res 8, 106-108
59. 59 Shalit F, Sredni B, Brodie C, Kott E, Huberman M (1995) T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin Immunol Immunopathol 75, 246-250
60. 60 Van Rensburg SJ, Daniels WM, Van Zyl J, Potochnik FC, Van der Walt J, Taljaard JJ (1994) Lipid peroxidation and platelet membrane fluidity - implications for Alzheimer's disease? Neuroreport 5, 2221-2224
61. 61 Zubenko GS, Teply I, Winwood E, Huff FJ, Moossy J, Sunderland T, Martinez AJ (1996) Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at five years. Am J Psychiatry 153, 420-423
62. 62 Lejoyeux M, Adès M, Roudier M, Daveloose D, Viret J, Mazière JC (1993) No change in viscosity of lipid phase of RBC membrane in Alzheimer's disease. Psychiatry Res 46, 203-205
63. 63 Eagger S, Hajiohammadreza I, Fletcher K, Levy R, Brammer M (1990) Platelet membrane fluidity, family history, severity and age of onset in Alzheimer's disease. Int J Ger Psychiat 5, 395-400
64. 64 Hajimohmmadreza I, Brammer MJ, Eagger S, Burns A, Levy R (1990) Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim Biophys Acta 1025, 208-214
65. 65 Hicks N, Brammer MJ, Hymas N, Levy R (1987) Platelet membrane properties in Alzheimer and multi-infarct dementias. Alzheimer Dis Assoc Disord 1, 90-97
66. 66 Walter H, Widen KE, Read SL (1993) Red blood cells from Alzheimer patients and from normal subjects discerned by cell electrophoresis in an aqueous polymer solution. Biochem Biophys Res Commun 194, 23-28
67. 67 Walter H, Widen KE (1995) Differential electrophoretic behavior in aqueous polymer solutions of red blood cells from Alzheimer's patients and from normal individuals. Biochim Biophys Acta 1234, 184-190
68. 68 Sabolovic' D, Roudier M, Boynard M, Pautou C, Sestier C, Fertil B, Geldwerth D, Roger J, Pons JN, Amri A, Halbreich A (1997) Membrane modifications of red blood cells in Alzheimer's disease. J Gerntol Biol Sci 52A, B217-B220
69. 69 Hardeman MR, Bauersachs RM, Meiselman HJ (1988) RBC laser diffractometry and RBC aggregometry with a rotational viscometer: Comparison with rheoscope and myrenne aggregometer. Clin Hemorheol 8, 581-593
70. 70 Boynard M, Ribier F, Guillet R, Driss F, Perrotin P, Gaudey F, Pautou C, Nalpas B (1994) Assessment of red blood cell deformability in healthy adult subjects: influence of sex, age, cigarette smoking, menstrual cycle and oral contraceptives. Clin Hemorheol 14, 225-262
71. 71 Iwaguchi T, Shimizu M, Mori T, Nakajima T (1984) Analysis of electrophoretic mobility histogram of mouse thymocytes during tumor development. Immunology 52, 359-365
72. 72 Sauer A, Kurzion T, Meyerstein D, Meyerstein N (1991) Kinetics of hemolysis of normal and abnormal red blood cells in glycerol-containing media. Biochim Biophys Acta 1063, 203-208
73. 73 Hayashi H, Fujii M, Yoshikumi C, Kawai Y, Watanabe N, Watanabe K, Fusama M, Shishido H (1987) Changes in electrophoretic mobility pattern of erythrocytes in patients with paroxysmal nocturnal hemoglobulinuria. J Clin Lab Immunol 23, 77-81
74. 74 Hosmer DW, Stanley L (1989). Applied Logistic Regression. Wiley and Sons Inc, New York
75. 75 Shigenaga MK, Hagen TM, Ames BN (1994) Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91, 10771-10778
76. 76 Mutisya EM, Bowling AC, Beal MF (1994). Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochemistry 63, 2179-2184
77. 77 Chandrasekaran K, Giordano T, Brady DR, Stoll J, Martin LJ, Rapoport SI (1994) Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Mol Brain Res 24, 336-340
78. 78 Weisenberg E, Halbreich A, Mager J (1980) Biochemical lesions in copper-deficient rats caused by secondary iron deficiency. Biochem J 188, 633-641
79. 79 Freudenberg H, Halbreich A, Mager J (1970) On the mechanism of inhibition of protein synthesis caused by intracellular ATP depletion and its relation to the fluoride-induced inhibition. Israel J Chem 8, 131 p
80. 80 Hamburger-Heyd J, Halbreich A, Mager J (1967) Reduced rate of ATP catabolism and the enhanced amino acid incorporating activity of regenerating rat liver microsomes. Biochem Biophys Res Commun 26, 471-476
81. 81 Jordan A, Wust P, Scholz R, Faehling H, Krause J, Felix R (1997) Magnetic fluid hyperthermia (MFH) in scientific and clinical applications of magnetic carriers (Häfeli U et al, eds) Plenum Press, NewYork, 569-595